These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1284 related articles for article (PubMed ID: 30546055)
41. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ. Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125 [TBL] [Abstract][Full Text] [Related]
42. Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice. Moya IM; Castaldo SA; Van den Mooter L; Soheily S; Sansores-Garcia L; Jacobs J; Mannaerts I; Xie J; Verboven E; Hillen H; Algueró-Nadal A; Karaman R; Van Haele M; Kowalczyk W; De Waegeneer M; Verhulst S; Karras P; van Huffel L; Zender L; Marine JC; Roskams T; Johnson R; Aerts S; van Grunsven LA; Halder G Science; 2019 Nov; 366(6468):1029-1034. PubMed ID: 31754005 [TBL] [Abstract][Full Text] [Related]
43. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1. Hansen CG; Ng YL; Lam WL; Plouffe SW; Guan KL Cell Res; 2015 Dec; 25(12):1299-313. PubMed ID: 26611634 [TBL] [Abstract][Full Text] [Related]
44. Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration. Liu C; Cheng X; Chen J; Wang Y; Wu X; Tian R; Liu B; Ding X; Sun Q; Gong W Theranostics; 2019; 9(13):3840-3852. PubMed ID: 31281517 [No Abstract] [Full Text] [Related]
45. The novel YAP target gene, SGK1, upregulates TAZ activity by blocking GSK3β-mediated TAZ destabilization. Yoo G; Kim T; Chung C; Hwang DS; Lim DS Biochem Biophys Res Commun; 2017 Aug; 490(3):650-656. PubMed ID: 28634071 [TBL] [Abstract][Full Text] [Related]
46. [Research advances in the role of the Hippo-YAP/TAZ signaling pathway in primary liver cancer]. Guo LW; Shao GL Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):878-880. PubMed ID: 29325286 [TBL] [Abstract][Full Text] [Related]
47. A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy. Pobbati AV; Hong W Theranostics; 2020; 10(8):3622-3635. PubMed ID: 32206112 [TBL] [Abstract][Full Text] [Related]
48. Biomolecular condensates: hubs of Hippo-YAP/TAZ signaling in cancer. Kiang KM; Ahad L; Zhong X; Lu QR Trends Cell Biol; 2024 Jul; 34(7):566-577. PubMed ID: 38806345 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model. Lee J; Jung Y; Jeong SW; Jeong GH; Moon GT; Kim M Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477764 [TBL] [Abstract][Full Text] [Related]
50. The regulation of Yorkie, YAP and TAZ: new insights into the Hippo pathway. Manning SA; Kroeger B; Harvey KF Development; 2020 Apr; 147(8):. PubMed ID: 32341025 [TBL] [Abstract][Full Text] [Related]
52. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells. Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487 [TBL] [Abstract][Full Text] [Related]
53. Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function. Sun C; De Mello V; Mohamed A; Ortuste Quiroga HP; Garcia-Munoz A; Al Bloshi A; Tremblay AM; von Kriegsheim A; Collie-Duguid E; Vargesson N; Matallanas D; Wackerhage H; Zammit PS Stem Cells; 2017 Aug; 35(8):1958-1972. PubMed ID: 28589555 [TBL] [Abstract][Full Text] [Related]
54. Role of the transcriptional coactivators YAP/TAZ in liver cancer. Zhang S; Zhou D Curr Opin Cell Biol; 2019 Dec; 61():64-71. PubMed ID: 31387016 [TBL] [Abstract][Full Text] [Related]
56. Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis. Verboven E; Moya IM; Sansores-Garcia L; Xie J; Hillen H; Kowalczyk W; Vella G; Verhulst S; Castaldo SA; Algueró-Nadal A; Romanelli L; Mercader-Celma C; Souza NA; Soheily S; Van Huffel L; Van Brussel T; Lambrechts D; Roskams T; Lemaigre FP; Bergers G; van Grunsven LA; Halder G Gastroenterology; 2021 Feb; 160(3):847-862. PubMed ID: 33127392 [TBL] [Abstract][Full Text] [Related]
57. The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number. Lavado A; Park JY; Paré J; Finkelstein D; Pan H; Xu B; Fan Y; Kumar RP; Neale G; Kwak YD; McKinnon PJ; Johnson RL; Cao X Dev Cell; 2018 Dec; 47(5):576-591.e8. PubMed ID: 30523785 [TBL] [Abstract][Full Text] [Related]
58. Hypoxic conditions differentially regulate TAZ and YAP in cancer cells. Yan L; Cai Q; Xu Y Arch Biochem Biophys; 2014 Nov; 562():31-6. PubMed ID: 25078107 [TBL] [Abstract][Full Text] [Related]